Viking Therapeutics Reveals Groundbreaking Results for Obesity Pill: Stock Skyrockets Overnight
San Diego, CA – Viking Therapeutics announced positive results for its new obesity pill, showing higher weight loss at increased dosages. The stock for Viking surged overnight, indicating a potential breakout from its current base. During the ObesityWeek meeting, Viking presented data showing that patients who took 100-miligram doses of VK2735 lost 8.2% of their body weight after 28 days, outperforming those on a placebo by 6.8%. The study included 92 individuals who received various …